Intelligent Bio Solutions Shares Preliminary Q4 Revenue Of $730K; FY24 Revenue Of $3.11M
Portfolio Pulse from Benzinga Newsdesk
Intelligent Bio Solutions Inc. (NASDAQ:INBS) reported preliminary unaudited revenue for Q4 and FY24, showing significant growth of 64% and 148% year-over-year, respectively. The company also anticipates increases in cartridge and reader sales.
September 09, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Intelligent Bio Solutions Inc. reported significant revenue growth for Q4 and FY24, with increases of 64% and 148% year-over-year, respectively. The company also expects a 20% increase in cartridge sales and a 26% increase in reader sales.
The reported revenue growth of 64% for Q4 and 148% for FY24 is a strong indicator of the company's positive performance. The expected increase in sales of cartridges and readers further supports a positive outlook for the company's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100